Related Experiment Video
Updated: Mar 19, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Hemodialysis-induced regional left ventricular systolic dysfunction
Yuxin Nie1,2, Zhen Zhang1,2, Jianzhou Zou1,2,3
1Division of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Insights
Hemodialysis (HD) can cause left ventricular (LV) systolic dysfunction in most patients, leading to regional wall motion abnormalities (RWMAs). Better interdialytic weight gain management is crucial for reducing this risk.
Area of Science:
- Cardiology
- Nephrology
- Medical Imaging
Background:
- Hemodialysis (HD) patients exhibit high cardiovascular mortality, often linked to cardiac dysfunction.
- Repetitive myocardial ischemia during HD can induce left ventricular (LV) systolic dysfunction.
- Understanding HD-induced cardiac dysfunction is vital for improving patient outcomes.
Purpose of the Study:
- To evaluate the prevalence of HD-induced LV systolic dysfunction.
- To identify potential risk factors associated with this dysfunction.
- To provide evidence for clinical strategies to mitigate cardiac risks in HD patients.
Main Methods:
- 31 standard HD patients underwent echocardiography before, during, and after dialysis.
- Auto functional imaging (AFI) assessed regional wall motion abnormalities (RWMAs).
- Biochemical variables and interdialytic weight gain (IDWG) were analyzed.
Main Results:
- 93.54% of patients and 51.40% of myocardial segments showed RWMAs.
- Severe RWMAs were associated with higher cTnT, phosphate, UFR, and lower albumin levels.
- Interdialytic weight gain (IDWG) was identified as an independent risk factor for severe RWMAs.
Conclusions:
- HD-induced LV systolic dysfunction is highly prevalent in HD patients.
- Effective interdialytic weight management is essential to reduce ultrafiltration rates and mitigate RWMAs.
- Clinical strategies should focus on weight control to prevent cardiac complications in HD patients.
Abstract:
Introduction Hemodialysis (HD) patients are under observably elevated cardiovascular mortality. Cardiac dysfunction is closely related to death caused by cardiovascular diseases (CVD). In the general population, repetitive myocardial ischemia induced left ventricular (LV) dysfunction may progress to irreversible loss of contraction step by step, and finally lead to cardiac death. In HD patients, to remove water and solute accumulated from 48 or 72 hours of interdialysis period in a 4-hour HD session will induce myocardial ischemia. In this study, we evaluated the prevalence and potential risk factors associated with HD-induced LV systolic dysfunction and provide some evidences for clinical strategies. Methods We recruited 31 standard HD patients for this study from Fudan University Zhongshan hospital. Echocardiography was performed predialysis, at peak stress during HD (15 minutes prior to the end of dialysis), and 30 minutes after HD. Auto functional imaging (AFI) was used to assess the incidence and persistence of HD-induced regional wall motion abnormalities (RWMAs). Blood samples were drawn to measure biochemical variables. Findings Among totally 527 segments of 31 patients, 93.54% (29/31) patients and 51.40% (276/527) segments were diagnosed as RWMAs. Higher cTnT (0.060 ± 0.030 vs. 0.048 ± 0.015 ng/mL, P = 0.023), phosphate (2.07 ± 0.50 vs. 1.49 ± 0.96 mmol/L, P = 0.001), UFR (11.00 ± 3.89 vs. 8.30 ± 2.66 mL/Kg/h, P = 0.039) and lower albumin (37.83 ± 4.48 vs. 38.38 ± 2.53 g/L, P = 0.050) were found in patients with severe RWMAs (RWMAs in more than 50% segments). After univariate and multivariate analysis, interdialytic weight gain (IDWG) was found as independent risk factor of severe RWMAs (OR = 1.047, 95%CI 1.155-4.732, P = 0.038). Discussion LV systolic dysfunction induced by HD is prevalent in conventional HD patients and should be paid attention to. Patients would benefit from better weight control during interdialytic period to reduce ultrafiltration rate.
More Related Videos
08:21Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
Related Concept Videos
Heart Failure II: Pathophysiology
Hemodialysis II: Procedure and Complications
Heart Failure III: Clinical Manifestations
Mitral Regurgitation I: Introduction
Heart Failure Drugs: Diuretics
Pathophysiology of Heart Failure